Cell line technology
By Frances Griss
One of the most exciting and rapidly growing fields of bioscience is the development of new cell lines with specific and controllable characteristics, either for research or industrial scale production.
Companies all over...
Understanding climate change and infectious disease: is the one health movement enough?
1 University of Reading, School of Agriculture, Policy and Development, Livestock Development Group
1&2 University of Reading, Walker Institute for Climate Research
In the coming decades, climate change is predicted to produce a range of direct...
The Great British Biosimilar Journey
Attitudes towards biosimilar drugs have rapidly changed in the last 24 months, but there is still work to do. Divya Chadha Manek from the National Institute for Health Research (NIHR) – the research arm...
Combatting antibiotic resistance
In the UK alone, the government estimates there are currently 5,000 deaths each year because antibiotics no longer work for some infections. Worldwide, drug-resistant infections are set to kill more people than cancer and...
Developing long term relationships with the skilled workers of the future
Despite the great demand for skilled workers in the STEM industries, employers are struggling to find and retain the young people with the skills and knowledge necessary to succeed in the workplace.
A recent survey...
Controlling Temperature with BioPharma Dynamics
BioPharma Dynamics discuss the importance of controlling parameters in your process.
Temperature monitoring and control devices are an integral part of any laboratory within the pharmaceutical sector. Having a quality temperature control system in place...
Putting the diverse into neurodiversity
The global Institute Of Neurodiversity ION has launched its UK chapter.
The Institute aims to give a global voice to all neurodiverse groups, and ensure neurodivergent individuals are understood, represented, and valued equally in society.
Currently, 1 in...
DMT-assisted therapy: changing the way we think about depressive disorders
A ‘spirit molecule’ from the Amazon could be a game changer in the treatment of major depressive disorders. Dr Carol Routledge, of Small Pharma, talks to Karen Southern about her pioneering work with DMT.
Psychedelic...
INDUSTRY-ACADEMIA PARTNERSHIP LAUNCHES ONE STEP MANUFACTURING PROCESS FOR PHARMACEUTICAL DOSAGE FORMS
Cubi-Tech Extrusion Limited, a Cubic Pharmaceuticals Ltd company, puts an end to some of the problems inherent in pharmaceuticals production.
Process efficiency and continuous manufacturing are certainly hot topics in the pharmaceutical industry right now,...
No time to breathe easy as the battle against asthma intensifies
Asthma is one of those conditions that can strike the very young and stay with them as they head into old age, often developing over many years into the more serious illness Chronic Obstructive...
The hidden way to fill vacancies, train and retain
The BSc (Hons) Biomedical Science (pathology lab based) degree apprenticeship has been developed through consultation with pathology laboratory employers and is co-delivered, meeting the requirements for a Healthcare Science Practitioner (Biomedical Scientist) apprenticeship.
The programme...
Biosimilars ‘making progress in the UK’
However, there still remain challenges for biosimilar companies trying to gain a foothold in the market, with reticence on the part of health trusts and clinicians taking time to break down.
The UK is an...
Depression up, Covid-19 down in disease study list
Depression is now one of the top five most studied disease areas in clinical development, according to new global analysis by Phesi.
The mid-year analysis of all this year’s trials to date reveals that Covid-19...
The power of ideas
Information lies at the heart of everything we do. We are surrounded by information technology and it allows us to look at life with different eyes.
In fact, the development of information, could, it be...
New treatment on horizon against ‘parasite’ mitochondria
A groundbreaking study has solved the old enigma in mitochondrial DNA disorders and advances the prospect of enhanced treatments for patients.
It not only resolves a long-standing conundrum in the molecular pathology of mitochondrial disease,...